HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefano Doccini Selected Research

Spastic ataxia Charlevoix-Saguenay type

7/2022In vitro study of polydopamine nanoparticles as protective antioxidant agents in fibroblasts derived from ARSACS patients.
8/2021Efficient Neuroprotective Rescue of Sacsin-Related Disease Phenotypes in Zebrafish.
6/2020Development of Nanostructured Lipid Carriers for the Delivery of Idebenone in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
1/2020Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefano Doccini Research Topics

Disease

4Spastic ataxia Charlevoix-Saguenay type
07/2022 - 01/2020
4Mitochondrial Diseases (Mitochondrial Disease)
07/2022 - 01/2020
2Necrosis
07/2022 - 08/2020
2Neoplasms (Cancer)
01/2022 - 08/2020
2Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/2022 - 01/2020
2Epilepsy (Aura)
01/2022 - 12/2019
2Seizures (Absence Seizure)
12/2019 - 01/2014
1Cerebellar Ataxia (Dysmetria)
01/2022
1Disease Progression
08/2021
1Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)
08/2021
1Atrophy
08/2021
1Melanoma (Melanoma, Malignant)
08/2020
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2020
1Spastic Ataxia
01/2020
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2020
1Usher Syndromes (Usher Syndrome)
01/2020
1Epilepsia Partialis Continua
12/2019
1Inflammation (Inflammations)
11/2019
1Ischemia
01/2018
1Muscular Dystrophies (Muscular Dystrophy)
12/2016
1Intellectual Disability (Idiocy)
01/2014

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2020
3AntioxidantsIBA
07/2022 - 11/2019
3MicroRNAs (MicroRNA)IBA
08/2020 - 01/2018
2idebenoneIBA
07/2022 - 06/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2020
2Amino AcidsFDA Link
01/2020 - 01/2014
2EnzymesIBA
01/2020 - 11/2019
1phenyl di-n-pentylphosphinateIBA
07/2022
1ResveratrolIBA
07/2022
1polydopamineIBA
07/2022
1Pharmaceutical PreparationsIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2021
1Mitochondrial DNA (mtDNA)IBA
07/2021
1ProteomeIBA
07/2021
1LuciferasesIBA
08/2020
1Adenosine Triphosphate (ATP)IBA
06/2020
1LipidsIBA
06/2020
1Adenosine Triphosphatases (ATPase)IBA
01/2020
1Transfer RNA (tRNA)IBA
01/2020
1Histidine (L-Histidine)FDA Link
01/2020
1Histidine-tRNA LigaseIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2019
1Immunoglobulins (Immunoglobulin)IBA
12/2019
1Matrix Metalloproteinases (MMPs)IBA
11/2019
1oleaceinIBA
11/2019
1oleocanthalIBA
11/2019
1PolyphenolsIBA
11/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019
1NADPH Oxidases (NAD(P)H oxidase)IBA
11/2019
1Olive OilIBA
11/2019
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2018
13- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA
12/2016
1Dystroglycans (Dystroglycan)IBA
12/2016
1dolichyl-phosphate beta-D-mannosyltransferaseIBA
12/2016
1aminoacylase I (aminoacylase)IBA
01/2014

Therapy/Procedure

2Therapeutics
08/2021 - 06/2020